Biosynex SA (EPA:ALBIO)
France
· Delayed Price · Currency is EUR 1.240
+0.005 (0.40%)
May 16, 2025, 4:46 PM CET
Biosynex Revenue
In the year 2024, Biosynex had annual revenue of 123.98M EUR with 33.35% growth. Biosynex had revenue of 53.74M in the half year ending June 30, 2024, a decrease of -62.22%.
Revenue
123.98M
Revenue Growth
+13.47%
P/S Ratio
0.23
Revenue / Employee
212.54K
Employees
569
Market Cap
23.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 123.98M | 31.00M | 33.35% |
| Dec 31, 2023 | 92.98M | -103.61M | -52.70% |
| Dec 31, 2022 | 196.59M | -185.95M | -48.61% |
| Dec 31, 2021 | 382.53M | 228.64M | 148.57% |
| Dec 31, 2020 | 153.90M | 118.72M | 337.54% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sanofi | 45.17B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |